Search - tctmd.com

Displaying 141 - 160 of 294

Sort: Relevancy | Date

News Conference News ESC 2017

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

Todd Neale

August 26, 2017

Presentation iASSESS 2017

STEMI: Treatment Strategies, Drugs And Devices

Presenter: Dharam J. Kumbhani

August 24, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

Presentation

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

August 18, 2017

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Todd Neale

August 18, 2017

News Daily News

PET More Accurate for Diagnosing CAD Than SPECT and CT Angiography: PACIFIC Study

Michael O'Riordan

August 17, 2017

Presentation

Comparison of CCTA, SPECT, PET, and Hybrid Imaging for Diagnosing CAD Determined by FFR

August 17, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Daily News

Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared

Todd Neale

August 15, 2017

Presentation

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

August 14, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

Presentation CHIP Seattle 2017

Instent Restenosis

Presenter: Creighton W. Don

August 11, 2017

Presentation CHIP Seattle 2017

CABG vs PCI vs Mechanical Support

Presenter: Jason W. Smith

August 11, 2017

Presentation CHIP Seattle 2017

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

Presenter: Ajay J. Kirtane

August 10, 2017

Presentation

Optimized Screening of CAD With Invasive Coronary Angiography and Ad Hoc PCI During TAVR

August 10, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Daily News

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

Michael O'Riordan

August 08, 2017

News Industry News

AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device

August 08, 2017

Presentation

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

August 07, 2017

Advertisement

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease

STEMI: Treatment Strategies, Drugs And Devices

Evolocumab Not Cost-Effective at Current List Price

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Comparative Efficacy and Safety of Reperfusion Therapy With Fibrinolytic Agents in STEMI Patients

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

PET More Accurate for Diagnosing CAD Than SPECT and CT Angiography: PACIFIC Study

Comparison of CCTA, SPECT, PET, and Hybrid Imaging for Diagnosing CAD Determined by FFR

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared

Optimal Timing of an Invasive Strategy with NSTE ACS Patients

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Instent Restenosis

CABG vs PCI vs Mechanical Support

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

Optimized Screening of CAD With Invasive Coronary Angiography and Ad Hoc PCI During TAVR

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content